Academic literature on the topic 'Hypoglycemic activities'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hypoglycemic activities.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Hypoglycemic activities"
Hanggaresty, Mutiarani Dasha, and Ni Kadek Warditiani. "REVIEW OF POTENTIAL PLANTS IN INDONESIA AS AN ANTIDIABETIC WITH HYPOGLYCEMIC ACTIVITIES." Journal of Pharmaceutical Science and Application 3, no. 2 (December 1, 2021): 57. http://dx.doi.org/10.24843/jpsa.2021.v03.i02.p01.
Full textArya, Aditya, Shaik Nyamathulla, Mohamed Ibrahim Noordin, and Mustafa Ali Mohd. "Antioxidant and Hypoglycemic Activities of Leaf Extracts of Three PopularTerminaliaSpecies." E-Journal of Chemistry 9, no. 2 (2012): 883–92. http://dx.doi.org/10.1155/2012/859831.
Full textZhang, Entan, Anker Jon Hansen, Tadeusz Wieloch, and Martin Lauritzen. "Influence of MK-801 on Brain Extracellular Calcium and Potassium Activities in Severe Hypoglycemia." Journal of Cerebral Blood Flow & Metabolism 10, no. 1 (January 1990): 136–39. http://dx.doi.org/10.1038/jcbfm.1990.18.
Full textDasgupta, Tumpa, Amlan Ganguly, Muhammad Asaduzzaman, and Nazmul Qais. "Evaluation of Anti-microbial, Hypoglycemic and Anti-diarrheal activities of Setaria italica Seeds." Dhaka University Journal of Pharmaceutical Sciences 15, no. 1 (August 8, 2016): 31–35. http://dx.doi.org/10.3329/dujps.v15i1.29190.
Full textSiddiqui, Sadaf, Neetesh Kumar Jain, and Narendra Silawat. "Antidiabetic Activities of Extracts of Ficus bengalensis Linn." International Journal of Medical Sciences and Pharma Research 8, no. 2 (June 15, 2022): 35–38. http://dx.doi.org/10.22270/ijmspr.v8i2.35.
Full textNAKINCHAT, Somrudee, and Voravuth SOMSAK. "A Pilot Study on Antimalarial Effects of Moringa oleifera Leaf Extract in Plasmodium berghei Infection in Mice." Walailak Journal of Science and Technology (WJST) 15, no. 2 (November 3, 2017): 151–56. http://dx.doi.org/10.48048/wjst.2018.4593.
Full textKarim, Irin, Roni Roy, Md Rafiul Hoque, Sazzad Hosen, Tanaya Bhowmik, Israt Jahan Liya, Afroza Akter, and Mohammad Anwarul Basher. "Effect of sex differences in antinociceptive, antipyretic, hypoglycemia, hepatoprotective and antidiarrheal activities in mice model." Journal of Pharmacy & Pharmacognosy Research 8, no. 1 (January 1, 2020): 569–79. http://dx.doi.org/10.56499/jppres20.911_8.6.569.
Full textHao, Jie, Zhiming Qian, Zijian Liu, Guirong Zhang, Di Wang, and Weiwei Han. "The Antidiabetic Activities of Neocryptotanshinone: Screened by Molecular Docking and Related to the Modulation of PTP1B." Nutrients 14, no. 15 (July 24, 2022): 3031. http://dx.doi.org/10.3390/nu14153031.
Full textMansur, Muhammad Abdullah Al, M. Mahboob Ali Siddiqi, and Koushik Saha. "Thrombolytic, Membrane Stabilizing and Hypoglycemic Activities of Anethum sowa Linn." Dhaka University Journal of Pharmaceutical Sciences 17, no. 2 (December 4, 2018): 237–41. http://dx.doi.org/10.3329/dujps.v17i2.39181.
Full textTelushkin, P. K. "The intensity of lipid peroxidation processes, the activity of NADP-dependent dehydrogenases and proteases in rat brain with repeated administration of insulin." Problems of Endocrinology 44, no. 3 (June 6, 1998): 35–37. http://dx.doi.org/10.14341/probl199844335-37.
Full textDissertations / Theses on the topic "Hypoglycemic activities"
Jaishee, Nishika. "Phytochemical analysis of some ferns with reference to their antioxidant, hypoglycemic and antimicrobial activities." Thesis, University of North Bengal, 2016. http://ir.nbu.ac.in/hdl.handle.net/123456789/2747.
Full textLino, Cleide de Sousa. "Efeitos antidiabÃtico, antioxidante, analgÃsico e antiinflamatÃrio da fraÃÃo solÃvel em metanol e tiramina isolados de Cissus Verticillata." Universidade Federal do CearÃ, 2008. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=2158.
Full textIntroduÃÃo: A Cissus verticillata à uma planta, utilizada popularmente como antidiabÃtica e antiinflamatÃria, Objetivos: Investigar as atividades antidiabÃtica, analgÃsica, antiinflamatÃria e antioxidante da FraÃÃo SolÃvel em Metanol (FSM), FraÃÃo Rica em Tiramina (FRT) e tiramina (TIR) isolados de Cissus verticillata. Material e MÃtodos: Ratos Wistar, machos, foram tratados por via oral com a FSM (50 e 100 mg/kg), glibenclamida(GLI, 5 mg/kg), Ãgua destilada ou glicose), e o sangue coletado antes e 30, 60, 90 e 120 min apÃs à glicose (3g/kg) para medir a hipoglicemia. Na avaliaÃÃo da glicemia em ratos normais, os animais foram tratados com a FSM (100 mg/kg), GLI (5 mg/kg) ou Ãgua destilada e a glicemia medida antes e 5 dias depois do tratamento. O diabetes foi induzidos com aloxano (40 mg/kg, i.v) e apÃs 48 h, os animais foram tratados por via oral com a FSM (100 mg/kg), GLI (5 mg/kg) e TIR (2 e 4 mg/kg) e a glicemia determinada antes e 30, 60, 90 e 120 min apÃs à glicose. Outros grupos de animais diabÃticos foram tratados com a FSM (50 e 100 mg/kg), FRT (100 mg/kg), TIR (1- 4 mg/kg), GLI (2,5 e 5 mg/kg), MET (50 e 100 mg/kg) e 5 dias depois, o sangue foi coletado para avaliaÃÃo da glicemia, triglicerÃdios, VLDL, colesterol total, HDL, AST, ALT, urÃia e creatinina. Os animais que sobreviveram foram sacrificados, dissecados o pÃncreas e o fÃgado, e os ÃrgÃos foram usados para a avaliaÃÃo histopatolÃgica, sendo este Ãltimo tambÃm utilizado para avaliaÃÃo da atividade antioxidante (TBARS, GSH, catalase e nitritos/nitratos). Para determinaÃÃo da hemoglobina glicada in vitro foi utilizado sangue de ratos nÃo-diabÃticos incubados com D-glicose (50mM) e FSM ou TIR (50 g/ml). Na dosagem do glicogÃnio hepÃtico, ratos diabÃticos foram tratados por 10 dias com a FSM. A avaliaÃÃo da atividade analgÃsica foi realizada em camundongos Swiss, machos, tratados com a FSM (50 e 100 mg/kg, v.o.), TIR (1,2 e 4 mg/kg), GLI ( 5 mg/kg) e MOR (10 mg/kg,.) no teste da formalina. A atividade antiinflamatÃria foi analisada com os modelos do edema de pata induzido por carragenina ou dextrano, em ratos e camundongos tratados com FSM (50 e 100 e 200 mg/kg), TIR (1- 4 mg/kg), GLI ( 5 mg/kg), INDO (5 mg/kg) e CIPRO (5 e 10 mg/kg,v.o.). Resultados: A FSM demonstrou pequena atividade hipoglicemiante no teste de tolerÃncia a glicose em ratos normais e foi ineficaz em diabÃticos. A FSM reduziu a glicemia em ratos normais, enquanto a TIR nÃo teve efeito. O tratamento de ratos diabÃticos durante 5 dias com a FSM, FRT, TIR, GLI e MET reduziu a glicemia, triglicerÃdios, VLDL, urÃia e creatinina. Nenhuma potencializaÃÃo do efeito hipoglicÃmico foi observado com a associaÃÃo de FSM + TIR ou GLI + TIR. Os estudos histopatolÃgicos mostraram regeneraÃÃo das lesÃes e aumento do nÃmero de cÃlulas apÃs tratamento dos animais diabÃticos com a FSM, TIR e GLI. A FSM e TIR mostraram atividade antioxiodante, como aumento no nÃvel de GSH e reduÃÃo nos nÃveis de catalase e nitritos. A FRT aumentou somente o GSH. A FSM e TIR reduziram a hemoglobina glicada, demonstraram potente atividade analgÃsica, mas foram ineficazes como antiinflamatÃrias. A FSM e TIR nÃo reverteram a hiperglicemia induzida pelo diazÃxido, um bloqueador dos canais de potÃssio. MET e TIR reduziram a glicemia, triglicerÃdios, VLDL, urÃia e creatinina, e os efeitos hipoglicemiantes foram potencializados quando essas duas drogas foram associadas. ConclusÃo: Estes resultados confirmam a atividade hipoglicemiante da FSM. O mecanismo de aÃÃo nÃo parece ser similar aquele apresentado pelas sulfonilurÃias. A potencializaÃÃo do efeito hipoglicemiante da TIR foi observada apÃs sua associaÃÃo com MET, sugerindo que o mecanismo de aÃÃo dos constituintes hipoglicÃmicos de C. verticillata à similar ao das biguanidas. Posteriormente, a FSM e TIR apresentaram atividade antioxidante, reduzidos nÃveis de hemoglobina glicada, aumento do glicogÃnio hepÃtico, e no nÃmero de cÃlulas pancreÃticas, sugerindo que essas drogas diminuem a toxicidade hepÃtica e pancreÃtica. Embora a atividade antiinflamatÃria tenha sido marginal, seu efeito foi potencializado pela associaÃÃo com TIR, indicando que a TIR à um dos principais constituintes bioativos de Cissus verticillata.
IntroduÃÃo: A Cissus verticillata à uma planta, utilizada popularmente como antidiabÃtica e antiinflamatÃria, Objetivos: Investigar as atividades antidiabÃtica, analgÃsica, antiinflamatÃria e antioxidante da FraÃÃo SolÃvel em Metanol (FSM), FraÃÃo Rica em Tiramina (FRT) e tiramina (TIR) isolados de Cissus verticillata. Material e MÃtodos: Ratos Wistar, machos, foram tratados por via oral com a FSM (50 e 100 mg/kg), glibenclamida(GLI, 5 mg/kg), Ãgua destilada ou glicose), e o sangue coletado antes e 30, 60, 90 e 120 min apÃs à glicose (3g/kg) para medir a hipoglicemia. Na avaliaÃÃo da glicemia em ratos normais, os animais foram tratados com a FSM (100 mg/kg), GLI (5 mg/kg) ou Ãgua destilada e a glicemia medida antes e 5 dias depois do tratamento. O diabetes foi induzidos com aloxano (40 mg/kg, i.v) e apÃs 48 h, os animais foram tratados por via oral com a FSM (100 mg/kg), GLI (5 mg/kg) e TIR (2 e 4 mg/kg) e a glicemia determinada antes e 30, 60, 90 e 120 min apÃs à glicose. Outros grupos de animais diabÃticos foram tratados com a FSM (50 e 100 mg/kg), FRT (100 mg/kg), TIR (1- 4 mg/kg), GLI (2,5 e 5 mg/kg), MET (50 e 100 mg/kg) e 5 dias depois, o sangue foi coletado para avaliaÃÃo da glicemia, triglicerÃdios, VLDL, colesterol total, HDL, AST, ALT, urÃia e creatinina. Os animais que sobreviveram foram sacrificados, dissecados o pÃncreas e o fÃgado, e os ÃrgÃos foram usados para a avaliaÃÃo histopatolÃgica, sendo este Ãltimo tambÃm utilizado para avaliaÃÃo da atividade antioxidante (TBARS, GSH, catalase e nitritos/nitratos). Para determinaÃÃo da hemoglobina glicada in vitro foi utilizado sangue de ratos nÃo-diabÃticos incubados com D-glicose (50mM) e FSM ou TIR (50 g/ml). Na dosagem do glicogÃnio hepÃtico, ratos diabÃticos foram tratados por 10 dias com a FSM. A avaliaÃÃo da atividade analgÃsica foi realizada em camundongos Swiss, machos, tratados com a FSM (50 e 100 mg/kg, v.o.), TIR (1,2 e 4 mg/kg), GLI ( 5 mg/kg) e MOR (10 mg/kg,.) no teste da formalina. A atividade antiinflamatÃria foi analisada com os modelos do edema de pata induzido por carragenina ou dextrano, em ratos e camundongos tratados com FSM (50 e 100 e 200 mg/kg), TIR (1- 4 mg/kg), GLI ( 5 mg/kg), INDO (5 mg/kg) e CIPRO (5 e 10 mg/kg,v.o.). Resultados: A FSM demonstrou pequena atividade hipoglicemiante no teste de tolerÃncia a glicose em ratos normais e foi ineficaz em diabÃticos. A FSM reduziu a glicemia em ratos normais, enquanto a TIR nÃo teve efeito. O tratamento de ratos diabÃticos durante 5 dias com a FSM, FRT, TIR, GLI e MET reduziu a glicemia, triglicerÃdios, VLDL, urÃia e creatinina. Nenhuma potencializaÃÃo do efeito hipoglicÃmico foi observado com a associaÃÃo de FSM + TIR ou GLI + TIR. Os estudos histopatolÃgicos mostraram regeneraÃÃo das lesÃes e aumento do nÃmero de cÃlulas apÃs tratamento dos animais diabÃticos com a FSM, TIR e GLI. A FSM e TIR mostraram atividade antioxiodante, como aumento no nÃvel de GSH e reduÃÃo nos nÃveis de catalase e nitritos. A FRT aumentou somente o GSH. A FSM e TIR reduziram a hemoglobina glicada, demonstraram potente atividade analgÃsica, mas foram ineficazes como antiinflamatÃrias. A FSM e TIR nÃo reverteram a hiperglicemia induzida pelo diazÃxido, um bloqueador dos canais de potÃssio. MET e TIR reduziram a glicemia, triglicerÃdios, VLDL, urÃia e creatinina, e os efeitos hipoglicemiantes foram potencializados quando essas duas drogas foram associadas. ConclusÃo: Estes resultados confirmam a atividade hipoglicemiante da FSM. O mecanismo de aÃÃo nÃo parece ser similar aquele apresentado pelas sulfonilurÃias. A potencializaÃÃo do efeito hipoglicemiante da TIR foi observada apÃs sua associaÃÃo com MET, sugerindo que o mecanismo de aÃÃo dos constituintes hipoglicÃmicos de C. verticillata à similar ao das biguanidas. Posteriormente, a FSM e TIR apresentaram atividade antioxidante, reduzidos nÃveis de hemoglobina glicada, aumento do glicogÃnio hepÃtico, e no nÃmero de cÃlulas pancreÃticas, sugerindo que essas drogas diminuem a toxicidade hepÃtica e pancreÃtica. Embora a atividade antiinflamatÃria tenha sido marginal, seu efeito foi potencializado pela associaÃÃo com TIR, indicando que a TIR à um dos principais constituintes bioativos de Cissus verticillata.
"Evaluation of the anti-diabetic activities of non-starch polysaccharides extracted from the fruiting body of Hericium erinaceus." 2005. http://library.cuhk.edu.hk/record=b5892362.
Full textThesis submitted in: November 2004.
Thesis (M.Phil.)--Chinese University of Hong Kong, 2005.
Includes bibliographical references (leaves 151-176).
Abstracts in English and Chinese.
Thesis Committee --- p.i
Acknowledgement --- p.ii
Abstract (English Version) --- p.iii
Abstract (Chinese Version) --- p.v
Content Page --- p.vii
List of Tables --- p.xiii
List of Figures --- p.xv
Abbreviation --- p.xvii
Chapter Chapter 1 --- Introduction --- p.1
Chapter 1.1 --- Diabetes Mellitus --- p.1
Chapter 1.1.1 --- Epidemiology --- p.1
Chapter 1.1.2 --- Economic Impact --- p.3
Chapter 1.2 --- "Digestion, Absorption and Metabolism of Carbohydrates" --- p.4
Chapter 1.2.1 --- Carbohydrate Digestion --- p.4
Chapter 1.2.2 --- Carbohydrate Absorption --- p.6
Chapter 1.2.3 --- Insulin Secretion --- p.6
Chapter 1.3 --- Pathophysiology of Diabetes Mellitus --- p.7
Chapter 1.3.1 --- Insulin-Dependent Diabetes Mellitus (lDDM) --- p.7
Chapter 1.3.1.1 --- Genetics --- p.8
Chapter 1.3.1.2 --- Autoimmunity --- p.9
Chapter 1.3.2 --- Non-Insulin-Dependent Diabetes Mellitus (NlDDM) --- p.11
Chapter 1.3.2.1 --- Insulin Resistance --- p.11
Chapter 1.3.2.2 --- Impaired Insulin Secretion --- p.14
Chapter 1.4 --- Management of Diabetes Mellitus --- p.15
Chapter 1.4.1 --- Sulfonylureas --- p.15
Chapter 1.4.2 --- Biguanides --- p.16
Chapter 1.4.3 --- Problems Encountered in the Management of Diabetes --- p.16
Chapter 1.4.4 --- Role of Dietary Fiber in the Management of Diabetes Mellitus --- p.18
Chapter 1.4.4.1 --- Dietary Fiber and Gastric Emptying Time --- p.19
Chapter 1.4.4.2 --- Dietary Fiber and Glucose Absorption in Small Intestine --- p.20
Chapter 1.4.5 --- Other Natural Products used for Diabetes Treatment…… --- p.22
Chapter 1.5 --- Mushrooms --- p.22
Chapter 1.5.1 --- The Definition of Mushrooms --- p.23
Chapter 1.5.2 --- Nutritional Values of Mushrooms --- p.24
Chapter 1.5.3 --- Production of Mushrooms --- p.25
Chapter 1.6 --- Medicinal (Antidiabetic) Properties of Mushrooms --- p.28
Chapter 1.6.1 --- Ganoderma lucidum --- p.29
Chapter 1.6.2 --- Tremella aurantia --- p.33
Chapter 1.6.3 --- Auricularia auricula --- p.36
Chapter 1.6.4 --- Grifola frondosa --- p.37
Chapter 1.7 --- Medicinal Uses of Hericium erinaceus --- p.39
Chapter 1.7.1 --- HeLa Cell Proliferation Inhibitors --- p.39
Chapter 1.7.2 --- Induction of Growth of Nerve Cells --- p.42
Chapter 1.7.3 --- Antitumour Activity --- p.42
Chapter 1.7.4 --- Antidiabetic Effect --- p.43
Chapter 1.8 --- Objectives --- p.45
Chapter Chapter 2 --- Materials and Methods --- p.46
Chapter 2.1 --- Extraction of Polysaccharides from the Fruiting Body of H. erinaceus --- p.46
Chapter 2.1.1 --- Small-scale Extraction --- p.46
Chapter 2.1.2 --- Large-scale Extraction --- p.47
Chapter 2.2 --- Physico-Chemical Characterization of HE-polysaccharides --- p.52
Chapter 2.2.1 --- Carbohydrate Content: Phenol-Sulfuric Acid Method --- p.52
Chapter 2.2.2 --- Protein Content: Lowry Assay --- p.52
Chapter 2.2.3 --- Uronic Acid Content --- p.53
Chapter 2.2.4 --- Molecular Weight Determination by High Pressure Liquid Chromatography (HPLC) --- p.55
Chapter 2.2.5 --- Determination of Monosaccharide Composition of Non-Starch Polysaccharides by Gas Chromatography (GC) --- p.56
Chapter 2.2.5.1 --- Acid Depolymerisation --- p.56
Chapter 2.2.5.2 --- Neutral Sugar Derivatisation --- p.56
Chapter 2.2.5.3 --- Determination of Neutral Sugar Composition by Gas Chromatography (GC) --- p.57
Chapter 2.2.6 --- Structural Study of Polysaccharides by Methylation --- p.59
Chapter 2.2.6.1 --- Preparation of dry Dimethyl Sulfoxide (DMSO) --- p.59
Chapter 2.2.6.2 --- Preparation of Methylsulfinyl Methyl Sodium (CH3SOCH2-Na+) from the dry DMSO and Sodium Hydride --- p.59
Chapter 2.2.6.3 --- Methylation Procedure --- p.60
Chapter 2.2.6.4 --- Preparation of Partially Methylated Alditol Acetates (PMAAs) --- p.61
Chapter 2.2.6.5 --- Analysis of the PMAAs by GC --- p.62
Chapter 2.2.7 --- The Measurement of Viscosity --- p.62
Chapter 2.3 --- In vitro Hypoglycemic Tests of HE-Polysaccharides --- p.64
Chapter 2.3.1 --- Glucose Dialysis Retardation Index (GDRl) --- p.64
Chapter 2.3.1.1 --- Experimental Setup --- p.64
Chapter 2.3.1.2 --- Measurement of Glucose in the Dialysate --- p.65
Chapter 2.3.2 --- Inhibition of Amylolysis --- p.66
Chapter 2.3.2.1 --- Experimental Setup --- p.66
Chapter 2.3.2.2 --- Measurement of Maltose in the Dialysate --- p.66
Chapter 2.4 --- In vivo Hypoglycemic Evaluation of HE-Polysaccharides --- p.67
Chapter 2.4.1 --- Oral Glucose Tolerance Test (OGTT) --- p.67
Chapter 2.4.2 --- Induction of Type l Diabetes in Normal BALB/c Mice --- p.69
Chapter 2.4.2.1 --- lnduction Protocol --- p.69
Chapter 2.4.2.2 --- Measurement of Plasma Glucose Level --- p.70
Chapter 2.4.3 --- Hypoglycemic Test on Normal and Diabetic BALB/c Mice --- p.71
Chapter 2.4.4 --- Measurement of Insulin Level by Enzyme-Linked Immunoadsorbent Assay (ELlSA) --- p.72
Chapter 2.4.4.1 --- Plasma Samples used in ELlSA --- p.72
Chapter 2.4.4.2 --- Assay Procedure --- p.73
Chapter 2.5 --- Statistical Evaluation --- p.74
Chapter Chapter 3 --- Results and Discussion --- p.75
Chapter 3.1 --- Yield of Polysaccharides extracted from H. erinaceus --- p.75
Chapter 3.2 --- Physico-chemical Properties of HE Polysaccharides --- p.79
Chapter 3.2.1 --- "Carbohydrate, Protein and Uronic Acid Content" --- p.79
Chapter 3.2.2 --- Monosaccharide Compositions --- p.83
Chapter 3.2.3 --- Molecular Weight of the HE polysaccharides --- p.85
Chapter 3.2.4 --- Structure of HE polysaccharides --- p.90
Chapter 3.2.5 --- Conclusion for the Physico-chemical Properties of HE-Polysaccharides --- p.96
Chapter 3.2.6 --- Viscosity of HE Polysaccharides --- p.99
Chapter 3.3 --- In vitro Study of the Hypoglycemic Effect of HE-Polysaccharides --- p.101
Chapter 3.3.1 --- Glucose Dialysis Retardation Index (GDRl) --- p.101
Chapter 3.3.2 --- Inhibition of α-Amylase Activity --- p.105
Chapter 3.4 --- In vivo Hypoglycemic Evaluation of HE-Polysaccharides --- p.109
Chapter 3.4.1 --- In vivo Oral Glucose Tolerance Test (OGTT) in Normal Mice --- p.109
Chapter 3.4.1.1 --- Oral Glucose Tolerance Test --- p.109
Chapter 3.4.1.2 --- Effect of Change of Viscosity of HE Polysaccharide in the Gl Tract of Mice --- p.114
Chapter 3.4.2 --- Establishment of a Diabetic Murine Model --- p.120
Chapter 3.4.3 --- Hypoglycemic Activity of HE-polysaccharides in Normal Mice --- p.123
Chapter 3.4.4 --- Hypoglycemic Activity of HE-polysaccharides in Diabetic Mice --- p.126
Chapter 3.4.5 --- Change of Plasma Insulin Level in the Hypoglycemic Test --- p.132
Chapter 3.4.6 --- Comparison of Hypoglycemic Activity of HE-Polysaccharides in Normal and Diabetic mice --- p.139
Chapter 3.4.6.1 --- Severity of Diabetic Conditions lnduced --- p.139
Chapter 3.4.6.2 --- Change in Insulin Secretion --- p.140
Chapter 3.4.6.3 --- Glucose Transporter --- p.140
Chapter 3.5 --- Other Factors that Affect in vivo Hypoglycemic Activity of the HE-polysaccharides --- p.141
Chapter 3.5.1 --- Route of Administration: Oral Feeding and Intraperitoneal Injection --- p.141
Chapter 3.5.2 --- Molecular Mechanisms of Hypoglycemic Activity --- p.142
Chapter 3.5.3 --- Glucose Toxicity --- p.144
Chapter 3.5.3.1 --- Insulin Resistance --- p.144
Chapter 3.5.3.2 --- Impaired Insulin Secretion --- p.145
Chapter Chapter 4 --- Conclusions and Future Works --- p.147
References --- p.151
Hsu, Chih-Ming, and 許志明. "Study on the hypoglycemic and anti-inflammatory activities of natural products isolated from Cucurbita moschata." Thesis, 2011. http://ndltd.ncl.edu.tw/handle/58787094235716534344.
Full text國立屏東科技大學
生物科技研究所
100
Insulin resistance, the impaired sensitivity of tissues to insulin, is a causative factor for type 2 diabetes. Whereas the occurrence of insulin resistance is closely related to inflammation induced by cytokines such as TNF-α (tumor necrosis factor-α). Thus, anti-inflammation is suggested to be a strategy for treating and preventing insulin resistance and type 2 diabetes. Previously, fractions isolated from the crude extract of Cucurbita moschata were found to have hypoglycemic activities in diabetic mice. Eleven natural products were purified from these fractions. To obtain more insights about the hypoglycemic effect and mechanism of C. moschata, this study aimed to characterize the hypoglycemic effects and anti-inflammatory activities of these natural products. Among the eleven compounds, three of them, namely syringaresinol (NH40), ferulin acid (NH65) and (22E,24R)-24-methyl-6β-methoxy-5α-cholesta-7,22-diene-3β,5-diol (NH76) were found to increase glucose uptake of insulin-resistant cells in the presence of insulin, indicating an insulin sensitizer activity. Meanwhile, NH76 and 3β-hydroxy-(22E,24R)-ergosta-5,8,22-trien-7-one (NH86) could increase glucose uptake of normal cells and activate AMP-activated protein kinase, suggesting an insulin-like activity. NH65 and 4-ketopinoresinol (NH63) diminished TNF-α-induced expression of inducible nitric oxide synthase, implying an anti-inflammatory activity. Further investigation suggested that NH65 and NH40 activated the insulin signaling pathway in insulin-resistant cells. Meanwhile, NH76 was confirmed to activate the insulin signaling pathway in both normal cells and insulin-resistant cells. In conclusion, natural products from C. moschata exhibited multiple functions, including insulin-like, insulin sensitizer, and anti-inflammatory activities. These activities likely contribute to the hypoglycemic effect of C. moschata.
Book chapters on the topic "Hypoglycemic activities"
Shaaban, Hamdy A., and Amr Farouk. "Potential Antimicrobial Activities of Terpenoids." In Terpenoids: Recent Advances in Extraction, Biochemistry and Biotechnology, 279–97. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/9781681089645122010014.
Full textKumar Sahu, Pratap, and Prashant Tiwari. "Impact of Shodhana on Semecarpus anacardium Nuts." In Alternative Medicine - Update. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.94189.
Full textHernández-Vega, Josué Daniel, Erik G. Tovar-Pérez, and Ixchel Parola-Contreras. "Biologically Active Peptides from Pearl Millet [Pennisetum glaucum (L.) R.Br.], Foxtail Millet [Setaria italica (L.) P.Beauv.] and Finger Millet [Eleusine coracana (L.) Gaertn] Grains." In Frontiers in Bioactive Compounds, 76–93. BENTHAM SCIENCE PUBLISHERS, 2023. http://dx.doi.org/10.2174/9789815123340123040008.
Full textKielb, Daiane Sander, Amabília Daniella da Cruz, Fátima Terezinha Pelachini Farias, Teresa Cristina Gaio, and Marco Antonio Schueda. "Herbal medicine Cissus sicyoides as a complement to the treatment of type II Diabetes Mellitus." In The Evolution of Research in Health Sciences. Seven Editora, 2024. http://dx.doi.org/10.56238/sevened2024.006-009.
Full textRamos, Mateus Lima, Isabela Mota Ramos, Jonas Alves Vieira, Ananda Helena Nunes Cunha, Orlene Silva da Costa, Lis Vieira Cordeiro, and Alice Alves Cordeiro. "Evaluation of the biological activity of the medicinal plant pata-de-vaca (Bauhinia forficata L.) against the bacterium Escherichia coli, using a flow injection analysis system." In CONNECTING EXPERTISE MULTIDISCIPLINARY DEVELOPMENT FOR THE FUTURE. Seven Editora, 2023. http://dx.doi.org/10.56238/connexpemultidisdevolpfut-074.
Full textChaudhary, Priyanka, Shivika Sharma, and Vikas Sharma. "Exploring Plant Tissue Culture in Ocimum basilicum L." In In Vitro Propagation and Secondary Metabolite Production from Medicinal Plants: Current Trends (Part 2), 180–95. BENTHAM SCIENCE PUBLISHERS, 2024. http://dx.doi.org/10.2174/9789815196351124010009.
Full textNandikatti, Vijayalakshmi, M. Bujji Babu, K. J. Vergelia Jenifer, and Sk Abida. "Extraction, Isolation, Phytochemical Screening and Evaluation of Anti Oxidant and Hypoglycemic Activity of Methanolic Extract of Tagetes Patula Linn Flowers." In Current Trends in Drug Discovery, Development and Delivery (CTD4-2022), 666–72. Royal Society of Chemistry, 2023. http://dx.doi.org/10.1039/9781837671090-00666.
Full textAkinyinka Akinwumi, Kazeeem, Oluwole Olusoji Eleyowo, and Omolara Omowunmi Oladipo. "A Review on the Ethnobotanical Uses, Phytochemistry and Pharmacology Effect of Luffa cylindrica." In Pharmacognosy - Medicinal Plants [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.98405.
Full textYaldiz, Gulsum, and Mahmut Camlica. "Assessment of Secondary Metabolites with Different Uses of Fenugreek." In Legumes [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.99479.
Full textBashir, Rashida, Samra Tabassum, Ayoub Rashid, Shafiqur Rehman, Ahmad Adnan, and Rabia Ghaffar. "Bioactive Components of Root Vegetables." In Root Vegetables [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.105961.
Full textConference papers on the topic "Hypoglycemic activities"
Zhang, Jin-Xiu, Dan-Dan Gu, Xiao-Jing Zhao, Jun-Xia Zhao, Xiao-Xi Shui, Yan-Qin Wang, Zhi-Guang Qi, and Li-An Wang. "A Primary Study of the Antioxidant, Hypoglycemic, Hypolipidemic and Antitumor Activities of SLE." In 2015 International Conference on Medicine and Biopharmaceutical. WORLD SCIENTIFIC, 2016. http://dx.doi.org/10.1142/9789814719810_0106.
Full textYusakul, G., P. Saensom, N. Mitsantia, C. Pengdee, and W. Putalun. "High-performance liquid chromatography for analysis of corosolic acid in Lagerstroemia species and their hypoglycemic activities." In 67th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA) in cooperation with the French Society of Pharmacognosy AFERP. © Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-3399758.
Full textUrzeala, Constanta, and Mihaela Vlaiculescu. "UTILIZATION OF CONTINUOUS GLYCEMIC MONITORING SYSTEMS AND PHYSICAL EXERCISE IN THE DIABETIC CHILD." In eLSE 2015. Carol I National Defence University Publishing House, 2015. http://dx.doi.org/10.12753/2066-026x-15-235.
Full textLammi, Carmen. "From the bench to the bedside: the history of lupin bioactive peptides as useful ingredient for the prevention of metabolic syndrome." In 2022 AOCS Annual Meeting & Expo. American Oil Chemists' Society (AOCS), 2022. http://dx.doi.org/10.21748/bwgm4089.
Full textVasconcelos, Matheus Felipe de Souza, Francisco Tomaz Meneses de Oliveira, Rafael Zini Moreira da Silva, and Alex Michel Daoud. "Neurological and adrenal insufficiency symptons in adult x-linked adrenoleukodystrophy: case report." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.347.
Full textUrzeala, Constanta, and Mihaela Vlaiculescu. "TELEMEDICINE AND PHYSICAL EXERCISE FOR THE CHILD WITH DIABETES." In eLSE 2016. Carol I National Defence University Publishing House, 2016. http://dx.doi.org/10.12753/2066-026x-16-241.
Full text